Assyro AI

Orange Book product · Generic (ANDA)

NILOTINIB HYDROCHLORIDE

NILOTINIB HYDROCHLORIDE

Generic (ANDA)ANDA 209651TE ABRX HETERO LABS LTD V

At a glance

Nov 19, 2025

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 19, 2025

    7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

NILOTINIB HYDROCHLORIDE

Strength

EQ 150MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

AB

Application

ANDA 209651

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of NILOTINIB HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.